Literature DB >> 23297014

IL-8 but not other biomarkers of endothelial damage is associated with disease activity in patients with ankylosing spondylitis without treatment with anti-TNF agents.

Valderilio Feijó Azevedo1, J R Faria-Neto, Andrea Stinghen, Pedro G Lorencetti, Wagner P Miller, Beatriz P Gonçalves, Carla C Szyhta, Roberto Pecoits-Filho.   

Abstract

The objective of the study was to investigate the association between IL-8 and other biomarkers of endothelial dysfunction (MCP-1, V-CAM, I-CAM) and the disease activity scores in a sample of 54 patients with ankylosing spondylitis (AS) without use of biological agents. Fifty-four AS patients without treatment with anti-TNFs agents between 18 and 80 years old, who met modified New York criteria and at the same time the axial ASAS criteria, were evaluated using an epidemiological questionnaire that included among others clinical data, BASDAI, BASFI, ASQoL, ASDAS and plasma levels of CRP, ESR, MCP-1, IL-8, ICAM-1 and VCAM-1. IL-8 varied in proportion to disease activity rates (BASDAI and ASDAS) p < 0.05, being strongly correlated with the disease activity. The levels of adhesion molecules I-CAM and VCAM, as described in other studies, were positively correlated with predisposing factors for cardiovascular disease. IL-8 has shown to be strongly correlated with clinical markers of disease activity and inflammatory activity and may be an additional variable to the overall assessment of the activity of the AS.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23297014     DOI: 10.1007/s00296-012-2631-x

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  27 in total

1.  Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis.

Authors:  P C Taylor; A M Peters; E Paleolog; P T Chapman; M J Elliott; R McCloskey; M Feldmann; R N Maini
Journal:  Arthritis Rheum       Date:  2000-01

Review 2.  Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications.

Authors:  Armen Yuri Gasparyan; Antonios Stavropoulos-Kalinoglou; Dimitri P Mikhailidis; Karen M J Douglas; George D Kitas
Journal:  Rheumatol Int       Date:  2011-02       Impact factor: 2.631

3.  Diagnostic features of ankylosing spondylitis.

Authors:  M Dougados
Journal:  Br J Rheumatol       Date:  1995-04

4.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

5.  The involvement of NK cells in ankylosing spondylitis.

Authors:  Niva Azuz-Lieberman; Gal Markel; Sa'ar Mizrahi; Roi Gazit; Jacob Hanna; Hagit Achdout; Raizy Gruda; Gil Katz; Tal I Arnon; Shosh Battat; Ehud Zamir; Muhammed Adawi; Reuven Mader; Ofer Mandelboim
Journal:  Int Immunol       Date:  2005-06-03       Impact factor: 4.823

6.  Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Authors:  Chenglong Han; Don W Robinson; Monica V Hackett; L Clark Paramore; Kathy H Fraeman; Mohan V Bala
Journal:  J Rheumatol       Date:  2006-09-01       Impact factor: 4.666

7.  Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.

Authors:  S J Hwang; C M Ballantyne; A R Sharrett; L C Smith; C E Davis; A M Gotto; E Boerwinkle
Journal:  Circulation       Date:  1997-12-16       Impact factor: 29.690

Review 8.  Chemokines in vascular pathology (review).

Authors:  Stavros Apostolakis; Emmanouil G Papadakis; Elias Krambovitis; Demetrios A Spandidos
Journal:  Int J Mol Med       Date:  2006-05       Impact factor: 4.101

Review 9.  Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis.

Authors:  Mike J Peters; Irene E van der Horst-Bruinsma; Ben A Dijkmans; Michael T Nurmohamed
Journal:  Semin Arthritis Rheum       Date:  2004-12       Impact factor: 5.532

10.  The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.

Authors:  M Rudwaleit; D van der Heijde; R Landewé; J Listing; N Akkoc; J Brandt; J Braun; C T Chou; E Collantes-Estevez; M Dougados; F Huang; J Gu; M A Khan; Y Kirazli; W P Maksymowych; H Mielants; I J Sørensen; S Ozgocmen; E Roussou; R Valle-Oñate; U Weber; J Wei; J Sieper
Journal:  Ann Rheum Dis       Date:  2009-03-17       Impact factor: 19.103

View more
  9 in total

1.  Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients.

Authors:  Fernanda Genre; Raquel López-Mejías; José A Miranda-Filloy; Begoña Ubilla; Verónica Mijares; Beatriz Carnero-López; Inés Gómez-Acebo; Trinidad Dierssen-Sotos; Sara Remuzgo-Martínez; Ricardo Blanco; Trinitario Pina; Carlos González-Juanatey; Javier Llorca; Miguel A González-Gay
Journal:  Rheumatol Int       Date:  2015-07-05       Impact factor: 2.631

2.  Single Cell Transcriptome and Surface Epitope Analysis of Ankylosing Spondylitis Facilitates Disease Classification by Machine Learning.

Authors:  Samuel Alber; Sugandh Kumar; Jared Liu; Zhi-Ming Huang; Diana Paez; Julie Hong; Hsin-Wen Chang; Tina Bhutani; Lianne S Gensler; Wilson Liao
Journal:  Front Immunol       Date:  2022-05-13       Impact factor: 8.786

3.  The impact of chronic kidney disease and short-term treatment with rosiglitazone on plasma cell-free DNA levels.

Authors:  Amanda L McGuire; Nadia Urosevic; Doris T Chan; Gursharan Dogra; Timothy J J Inglis; Aron Chakera
Journal:  PPAR Res       Date:  2014-10-13       Impact factor: 4.964

4.  The role of Vitamin D in immuno-inflammatory responses in Ankylosing Spondylitis patients with and without Acute Anterior Uveitis.

Authors:  T C Mitulescu; C Stavaru; L M Voinea; L M Banica; C Matache; D Predeteanu
Journal:  J Med Life       Date:  2016 Jan-Mar

5.  Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis.

Authors:  Klára Prajzlerová; Kristýna Grobelná; Markéta Hušáková; Šárka Forejtová; Astrid Jüngel; Steffen Gay; Jiří Vencovský; Karel Pavelka; Ladislav Šenolt; Mária Filková
Journal:  PLoS One       Date:  2017-09-22       Impact factor: 3.240

6.  The Effect of Whole-Body Cryotherapy at Different Temperatures on Proinflammatory Cytokines, Oxidative Stress Parameters, and Disease Activity in Patients with Ankylosing Spondylitis.

Authors:  Anna Straburzyńska-Lupa; Magdalena Paulina Kasprzak; Mateusz Wojciech Romanowski; Anna Kwaśniewska; Wojciech Romanowski; Maria Iskra; Radosław Rutkowski
Journal:  Oxid Med Cell Longev       Date:  2018-10-03       Impact factor: 6.543

7.  Serum IL-6 correlates with axial mobility index (Bath Ankylosing Spondylitis Metrology Index) in Brazilian patients with ankylosing spondylitis.

Authors:  Cristina F Rabelo; Talita Siara Almeida Baptista; Laura Esteves Petersen; Moisés Evandro Bauer; Mauro Waldemar Keiserman; Henrique Luiz Staub
Journal:  Open Access Rheumatol       Date:  2018-04-30

8.  Screening of underlying genetic biomarkers for ankylosing spondylitis.

Authors:  Xutao Fan; Bao Qi; Longfei Ma; Fengyu Ma
Journal:  Mol Med Rep       Date:  2019-04-24       Impact factor: 2.952

9.  Active ankylosing spondylitis increases blood loss during total hip arthroplasty for a stiff hip joint.

Authors:  Yong Hu; Wei-Zhou Jiang; Cheng-Long Pan; Tao Wang
Journal:  BMC Musculoskelet Disord       Date:  2020-04-15       Impact factor: 2.362

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.